ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 115 filers reported holding ANAPTYSBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,396 | -16.9% | 30,590 | -5.9% | 0.00% | – |
| Q2 2023 | $661,457 | +6.3% | 32,520 | +13.7% | 0.00% | – |
| Q1 2023 | $622,336 | -38.4% | 28,600 | -12.3% | 0.00% | – |
| Q4 2022 | $1,010,274 | +21.4% | 32,600 | 0.0% | 0.00% | – |
| Q3 2022 | $832,000 | +25.7% | 32,600 | 0.0% | 0.00% | – |
| Q2 2022 | $662,000 | -6.1% | 32,600 | +14.4% | 0.00% | – |
| Q1 2022 | $705,000 | -28.6% | 28,500 | +0.4% | 0.00% | – |
| Q4 2021 | $987,000 | +19.8% | 28,400 | -6.6% | 0.00% | – |
| Q3 2021 | $824,000 | +4.6% | 30,400 | 0.0% | 0.00% | – |
| Q2 2021 | $788,000 | +32.9% | 30,400 | +10.5% | 0.00% | – |
| Q1 2021 | $593,000 | -11.4% | 27,500 | -11.6% | 0.00% | – |
| Q4 2020 | $669,000 | +40.8% | 31,100 | -3.4% | 0.00% | – |
| Q3 2020 | $475,000 | -33.9% | 32,200 | 0.0% | 0.00% | – |
| Q2 2020 | $719,000 | +39.3% | 32,200 | -11.7% | 0.00% | – |
| Q1 2020 | $516,000 | -71.2% | 36,486 | -66.9% | 0.00% | -100.0% |
| Q4 2019 | $1,790,000 | +40.2% | 110,130 | +201.8% | 0.00% | 0.0% |
| Q3 2019 | $1,277,000 | -36.6% | 36,486 | +2.2% | 0.00% | 0.0% |
| Q2 2019 | $2,013,000 | -4.0% | 35,686 | +24.4% | 0.00% | 0.0% |
| Q1 2019 | $2,096,000 | -51.7% | 28,686 | -57.9% | 0.00% | -66.7% |
| Q4 2018 | $4,343,000 | +54.4% | 68,086 | +141.6% | 0.00% | +50.0% |
| Q3 2018 | $2,812,000 | +40.5% | 28,186 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $2,002,000 | -20.5% | 28,186 | +16.5% | 0.00% | -50.0% |
| Q1 2018 | $2,517,000 | +19.1% | 24,186 | +15.2% | 0.00% | 0.0% |
| Q4 2017 | $2,114,000 | – | 20,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |